title: Should we investigate retinopathy in chronic hepatitis C patients receiving treatment with interferon?
authors.affiliation: aDepartment of Gastroenterology and Hepatology, Hepatology Unit bDepartment of Ophthalmology, La Mancha-Centro Hospital Complex, Alcázar de San Juan, Spain.
authors.forename: Sami
authors.initials: S
authors.lastname: Aoufi Rabih
authors.forename: Laura Blanca
authors.initials: LB
authors.lastname: Alfaya Muñoz
authors.forename: Alvaro
authors.initials: A
authors.lastname: Fidalgo Broncano
authors.forename: Rosanna
authors.initials: R
authors.lastname: Villanueva Hernández
authors.forename: Pedro
authors.initials: P
authors.lastname: González Carro
authors.forename: Francisco
authors.initials: F
authors.lastname: Pérez Roldán
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000009:adverse effects*; D005260:Female; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D015995:Prevalence; D012164:Retinal Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology; D012307:Risk Factors; D013030:Spain / Q000453:epidemiology; D041623:Tomography, Optical Coherence; D055815:Young Adult
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha